Table 4.
Characteristics (Total 1157 Doses) |
No. of Doses with EARs (N = 173) |
No. of Doses without EARs (N = 984) |
p-Value |
---|---|---|---|
Type of antivenom: N (%) | 0.897 | ||
Received antivenom for hematotoxic snakes | 126 (72.8) | 721 (72.4) | |
Received antivenom for neurotoxic snakes | 47 (27.2) | 272 (27.6) | |
Antivenom given dose:N (%): | 0.585 | ||
Appropriate dose | 165 (95.4) | 931 (94.6) | |
Lower than appropriate dose | 8 (4.6) | 47 (4.8) | |
Higher than appropriate dose | 0 (0) | 6 (0.6) | |
Duration of IV antivenom administration: | 0.002 * | ||
30–60 min (recommended method) | 158 (91.3) | 954 (97.0) | |
<30 min | 10 (5.8) | 16 (1.6) | |
>60 min | 5 (2.9) | 14 (1.4) |
EARs; early adverse reactions, N; number of doses of antivenom, IV; intravenous. * Statistically significant.